Rahaman, M. M., Singh, A., Medina, S. R., Tokuyama, N., Hammouda, K., Fu, P., Sandler, H. M., Correa, R. J. M., Chafe, S., Shah, A. I., Efstathiou, J. A., Hoffman, K. E., Straza, M. W., Hallman, M. A., Jordan, R., MIllar, E. K., Meijering, E., Pugh, S. L., Nguyen, P., Madabhushi, A. (2026). Spatial transcriptomics-guided pathology biomarker as a predictor of benefit of adjuvant docetaxel in high-risk localized prostate cancer: NRG/RTOG 0521 (NCT00288080).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5111